课题基金 / 基金详情

C-Detect, a monitoring and alerting wearable vital signs monitor.

C-Detect, a monitoring and alerting wearable vital signs monitor.
C-Detect,一款监测和警报可穿戴生命体征监测仪。
批准号:
73479
负责人:
金额:
$50.43万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
C-Detect是一种可穿戴式监测器,可检测可能感染COVID-19或检测呈阳性的人的病情恶化情况。C-Detect可以让用户知道他们是否可以自我隔离,因为他们的生命体征没有恶化,或者他们是否应该寻求帮助。该设备还包括蓝牙社交距离功能,并集成了Apple\\ b谷歌追踪程序。c - detect是由一个屡获殊荣的团队开发的,该团队与5所学术大学医院合作开发了一种新的最先进的生命体征监测仪。该设备必须具有医疗级别的准确性,但具有消费者级别的可用性。C-Detect是针对COVID-19的传感器的精简版。不仅在医院,而且在患者家中都通过了临床试验,将经过验证和测试的技术从我们的旗舰传感器过渡到C-Detect是一个自然的进展,使我们能够直接应对COVID-19。虽然检测很重要,但它并不能阻止人们被感染和传播病毒。使用C-Detect等设备进行持续监测,通过通知用户他们可能被感染并应自我隔离或寻求强有力的医疗援助,可以尽早阻止感染的传播。持续监测在除COVID以外的疾病中具有许多优势,因为在广泛的疾病中进行早期发现可以带来更好的患者结果和更便宜的治疗。
英文摘要
C-Detect is a wearable monitor detecting deterioration in people who may have COVID-19 or who have tested positive. C-Detect lets the user know if they can self-isolate as their vital signs are not deteriorating or if they should seek help. The device also includes a bluetooth social distancing feature and integration with the Apple\\Google tracing program.C-Detect has been developed by an award winning team who worked with 5 Academic University Hospitals to develop a new state-of-the-art, vital-signs monitor. The device had to have medical grade accuracy but with consumer levels of usability. C-Detect is a cut-down version of that sensor that has been targeted at COVID-19\.Having passed Clinical trials not only in hospitals but also in patients homes, transitioning tried and tested technology from our flagship sensor into C-Detect was a natural progression allowing us to address COVID-19 directly. Whilst testing is important, it does not stop people being infected and spreading the virus. Constant monitoring with a device such as C-Detect stops the spread of infection at the earliest time by informing the user that they may be infected and should self-isolate or seek robust medical assistance.Continuous monitoring delivers many advantages in conditions other than COVID as early detection in a wide range of conditions results in better patient outcomes and cheaper treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
  • 批准号:
    82372007
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    谢文晖
  • 依托单位: